BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 30, 2026
Home » Authors » Kim Coghill

Kim Coghill

Articles

ARTICLES

ImClone, BMS Meet With FDA; Next Steps To Be Determined

Feb. 27, 2002
By Kim Coghill

Inhale Strikes Three Deals For PEG Technology, One On THC

Feb. 27, 2002
By Kim Coghill
Inhale Therapeutic Systems Inc. said Tuesday that it recently signed three collaboration deals for use of its PEG injectable technology, and a fourth using its pulmonary technology. (BioWorld Today)
Read More

ImClone, BMS Meet With FDA; Next Steps To Be Determined

Feb. 27, 2002
By Kim Coghill

House Wants Information From Other Potential ImClone Partners

Feb. 25, 2002
By Kim Coghill
WASHINGTON - A House committee has asked seven pharmaceutical companies that negotiated with ImClone Systems Inc. to partner on Erbitux to turn over documentation and research related to those discussions. (BioWorld Today)
Read More

House Wants Information From Other Potential ImClone Partners

Feb. 25, 2002
By Kim Coghill
WASHINGTON - A House committee has asked seven pharmaceutical companies that negotiated with ImClone Systems Inc. to partner on Erbitux to turn over documentation and research related to those discussions. (BioWorld Today)
Read More

Bush Might Have Final Say On Biotech’s Role In Bioterrorism

Feb. 21, 2002
By Kim Coghill

Bush Might Have Final Say On Biotech’s Role In Bioterrorism

Feb. 21, 2002
By Kim Coghill

Beyond Genomics, DiaDexus To Develop Cancer Markers, Targets

Feb. 20, 2002
By Kim Coghill

Beyond Genomics, DiaDexus To Develop Cancer Markers, Targets

Feb. 20, 2002
By Kim Coghill

Curis Restructuring Includes Cutting Programs, Employees

Feb. 19, 2002
By Kim Coghill
Curis Inc. said it intends to cut employees and expenses as part of its effort to realign research and development programs to focus on signaling pathways and stem cell technology. (BioWorld Today)
Read More
View All Articles by Kim Coghill

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 29, 2026.
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing